PRKRA anticorps (AA 1-313)
-
- Antigène Voir toutes PRKRA Anticorps
- PRKRA (Protein Kinase, Interferon-Inducible Double Stranded RNA Dependent Activator (PRKRA))
-
Épitope
- AA 1-313
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp PRKRA est non-conjugé
-
Application
- ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
- Réactivité croisée
- Humain
- Purification
- >95%, Protein G purified
- Immunogène
- Recombinant Human Interferon-inducible double-stranded RNA-dependent protein kinase activator A protein (1-313AA)
- Isotype
- IgG
- Top Product
- Discover our top product PRKRA Anticorps primaire
-
-
- Indications d'application
- Recommended dilution: IHC:1:20-1:200, IF:1:50-1:500,
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- PRKRA (Protein Kinase, Interferon-Inducible Double Stranded RNA Dependent Activator (PRKRA))
- Autre désignation
- PRKRA (PRKRA Produits)
- Synonymes
- anticorps PRKRA, anticorps AV120107, anticorps PRK, anticorps Pact, anticorps RAX, anticorps lear, anticorps DYT16, anticorps PACT, anticorps im:7151758, anticorps zgc:162619, anticorps dyt16, anticorps pact, anticorps prkra-a, anticorps prkra-b, anticorps rax, anticorps rbpa, anticorps protein activator of interferon induced protein kinase EIF2AK2, anticorps protein kinase, interferon inducible double stranded RNA dependent activator, anticorps protein kinase, interferon-inducible double stranded RNA dependent activator, anticorps protein activator of interferon induced protein kinase EIF2AK2 L homeolog, anticorps PRKRA, anticorps Prkra, anticorps prkra, anticorps prkra.L
- Sujet
-
Background: Activates EIF2AK2/PKR in the absence of double-stranded RNA (dsRNA), leading to phosphorylation of EIF2S1/EFI2-alpha and inhibition of translation and induction of apoptosis. Required for siRNA production by DICER1 and for subsequent siRNA-mediated post-transcriptional gene silencing. Does not seem to be required for processing of pre-miRNA to miRNA by DICER1. Promotes UBC9-p53/TP53 association and sumoylation and phosphorylation of p53/TP53 at \\\'Lys-386\\\' at \\\'Ser-392\\\' respectively and enhances its activity in a EIF2AK2/PKR-dependent manner (By similarity).
Aliases: DYT16 antibody, HSD14 antibody, Interferon inducible double stranded RNA dependent protein kinase activator A antibody, interferon-inducible double stranded RNA-dependent activator antibody, Interferon-inducible double stranded RNA-dependent protein kinase activator A antibody, PACT antibody, PKR associated protein X antibody, PKR associating protein X antibody, PKR-associated protein X antibody, PKR-associating protein X antibody, PRKRA antibody, PRKRA_HUMAN antibody, Protein activator of the interferon induced protein kinase antibody, Protein activator of the interferon-induced protein kinase antibody, Protein kinase antibody, Protein kinase interferon inducible double stranded RNA dependent activator antibody, RAX antibody
- UniProt
- O75569
- Pathways
- Regulatory RNA Pathways
-